GLS2 and breast cancer: In contrast, expression of GLS2 can also be promoted by the oncogenic n-Myc protein (66), and upregulated GLS2 expression in breast cancer tissues is found to be correlated with poor patient prognosis (67, 68), indicating that the function of GLS2 may not be strictly suppressive.